Back

Biomarkers in risk assessment: will they ever be ready for clinical practice?

26 August 2018 (15:29 - 15:45)
Organised by:
Congress Presentation Part of: Something old, something new: biomarkers and cardiovascular risk assessment Cardiovascular Risk Assessment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Assistant Professor Nina Paynter

Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
State of the Art in biomarkers and cardiovascular risk assessment.
Professor M. Kavousi (Rotterdam, NL)
Presentation thumbnail
Screening multiple biomarkers for associations with cardiovascular death in patients with stable coronary heart disease
Professor L. Wallentin (Uppsala, SE)
Abstract Slides Video
Presentation thumbnail
Cardiovascular preoperative screening system for non-cardiac surgery modified from ACC/AHA guideline can provide effective evaluation.
Doctor S. Taniai (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Utility of high risk plaques detected by cardiac magnetic resonance for prediction of future coronary events adding on Framingham risk score in subjects without coronary artery disease.
Doctor H. Miura (Osaka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Something old, something new: biomarkers and cardiovascular risk assessment

The Event

Event poster

ESC Congress 2018

26 August 2018 15:29 CET
You may be interested in
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)